|
|
Article: New findings from Chinese Center for Disease Control and Prevention in the area of falciparum malaria therapy published.(Report)
- Article from:
- Biotech Week
- Article date:
- October 7, 2009
CopyrightCOPYRIGHT 2009 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Research findings, 'Molecular assessment of Plasmodium falciparum resistance to antimalarial drugs in China,' are discussed in a new report. "In China, Chloroquine (CQ) and sulfadoxine-pyrimethamine (SP) were abandoned for the treatment of falciparum malaria 20 years ago due to resistance. Subsequent field studies showed a trend of declining CQ and SP resistance in the country," scientists in Shanghai, People's Republic of China report (see also Falciparum Malaria Therapy).
"The main purpose of this study was to analyse the molecular markers of antimalarial resistance and thereby to assess the possibility of reintroduction of CQ or SP for falciparum malaria ...